You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
In Nature this week: Readfish tool for targeted nanopore sequencing, genomic diversity of barley and wheat, and more.
China increased the amount it spent on research and development by more than 10 percent in 2019, ScienceInsider says.
UK researchers said they are developing a commercial test that could enable sensitive detection of tuberculosis DNA in blood and provide an option to broaden screening.
In PNAS this week: core Pseudomonas aeruginosa genome, study of ancient Paget's disease of the bone, and more.
Early-access users of the Flongle said the small, inexpensive flow cells allow them to develop new methods quickly and to check the quality of clones and libraries.
Three long-read assemblies — two from PacBio data alone and one from Oxford Nanopore and Illumina data — had considerably more indel errors in genes than short-read assemblies.
The Guardian reports that labs in the UK have had safety incidents involving pathogens.
A genome-wide association study of children whose mothers had preeclampsia, conducted as part of the InterPregGen study, implicates variants near the FLT1 gene in the condition.
The Ebola virus may have mutated to better infect humans during the 2014 outbreak, the New York Times reports.
Data for tens of thousands of UK Biobank participants revealed an overlapping set of variants involved in airflow obstruction in heavy and never smokers.
The Wall Street Journal reports on gaps in COVID-19 testing affecting less affluent urban areas and rural locations.
According to NBC News, new SARS-CoV-2 variants are making it harder for researchers to model the course of the pandemic.
The New York Times reports that experts say President Joe Biden's goal of vaccinating 1 million people a day in the US in the next 100 days is too low a bar.
In Science this week: single-cell lineage tracing technique applied to study lung cancer metastasis, and more.